1
|
Cieśla J, Tomsia M. Cadaveric Stem Cells: Their Research Potential and Limitations. Front Genet 2022; 12:798161. [PMID: 35003228 PMCID: PMC8727551 DOI: 10.3389/fgene.2021.798161] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Accepted: 11/30/2021] [Indexed: 12/28/2022] Open
Abstract
In the era of growing interest in stem cells, the availability of donors for transplantation has become a problem. The isolation of embryonic and fetal cells raises ethical controversies, and the number of adult donors is deficient. Stem cells isolated from deceased donors, known as cadaveric stem cells (CaSCs), may alleviate this problem. So far, it was possible to isolate from deceased donors mesenchymal stem cells (MSCs), adipose delivered stem cells (ADSCs), neural stem cells (NSCs), retinal progenitor cells (RPCs), induced pluripotent stem cells (iPSCs), and hematopoietic stem cells (HSCs). Recent studies have shown that it is possible to collect and use CaSCs from cadavers, even these with an extended postmortem interval (PMI) provided proper storage conditions (like cadaver heparinization or liquid nitrogen storage) are maintained. The presented review summarizes the latest research on CaSCs and their current therapeutic applications. It describes the developments in thanatotranscriptome and scaffolding for cadaver cells, summarizes their potential applications in regenerative medicine, and lists their limitations, such as donor’s unknown medical condition in criminal cases, limited differentiation potential, higher risk of carcinogenesis, or changing DNA quality. Finally, the review underlines the need to develop procedures determining the safe CaSCs harvesting and use.
Collapse
Affiliation(s)
- Julia Cieśla
- School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
| | - Marcin Tomsia
- Department of Forensic Medicine and Forensic Toxicology, Medical University of Silesia, Katowice, Poland
| |
Collapse
|
2
|
Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells. Stem Cells Int 2019; 2019:5841587. [PMID: 31885618 PMCID: PMC6899284 DOI: 10.1155/2019/5841587] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2019] [Accepted: 09/04/2019] [Indexed: 01/01/2023] Open
Abstract
Stem cells can be isolated from various human tissues including bone marrow (BM) and adipose tissue (AT). Our study outlines a process to isolate adult stem cells from deceased donors. We have shown that cell counts obtained from deceased donor BM were within established living donor parameters. Evaluation of demographic information exhibited a higher percentage of hematopoietic stem cells (HSC) in males versus females, as well as a higher percentage of HSC in the age bracket of 25 years and under. For the first time, we show that deceased donor femur BM grew cell colonies. Our introduction of new technology for nonenzymatic AT processing significantly increased cell recovery over the traditional enzymatic processing method. Cell counts from the deceased donor AT exceeded living donor parameters. Furthermore, our data illustrated that AT from female donors yielded a much higher number of total nucleated cells (TNC) than males. Together, our data demonstrates that our approach to isolate stem cells from deceased donors could be a routine practice to provide a viable alternative to living donor stem cells. This will offer increased accessibility for patients awaiting stem cell therapies.
Collapse
|
3
|
Sun Y, Chi D, Tan M, Kang K, Zhang M, Jin X, Leng X, Cao R, Liu X, Yu B, Wu J. Cadaveric cardiosphere-derived cells can maintain regenerative capacity and improve the heart function of cardiomyopathy. Cell Cycle 2016; 15:1248-56. [PMID: 27058215 PMCID: PMC4889289 DOI: 10.1080/15384101.2016.1160973] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2015] [Revised: 02/23/2016] [Accepted: 02/26/2016] [Indexed: 12/31/2022] Open
Abstract
OBJECTIVE Cardiosphere-derived cells (CDCs) improve cardiac function and attenuate remodeling in ischemic and non-ischemic cardiomyopathy, and are currently obtained through myocardial biopsy. However, there is not any study on whether functional CDCs may be obtained through cadaveric autopsy with similar benefits in non-ischemic cardiomyopathy. METHODS Cardiac tissues from human or mouse cadavers were harvested, plated at 4°C, and removed at varying time points to culture human CDCs (CLH-EDCs) and mouse CDCs (CM-CDCs). The differentiation and paracrine effects of CDCs were also assessed. Furthermore, intramyocardial injection of cadaveric CM-CDCs was performed in an induced dilated cardiomyopathy (DCM) model. RESULTS With the extension of post mortem hours, the number of CLH-EDCs and CM-CDCs harvested from autopsy specimens decreased. The expressions of von Willebrand factor (VWF) and smooth muscle actin (SMA) on CDCs were gradually reduced, however, cardiac troponin I (TNI) expression increased in the 24 h group compared to the 0 h group. CLH-EDCs were also found to have similar paracrine function in the 24 h group compared to 0 h group. 8 weeks after CM-CDCs transplantion to the injured heart, mean left ventricular ejection fraction increased in both 0 h (64.99 ± 3.4%) and 24 h (62.99 ± 2.8%) CM-CDCs-treated groups as compared to the PBS treated group (53.64 ± 5.6 cm), with a decrease in left ventricular internal diastolic diameter (0.29 ± 0.08 cm and 0.32 ± 0.04 cm in 0 h and 24 h groups, vs. 0.41 ± 0.05 cm in PBS group). CONCLUSION CDCs from cadaveric autopsy are highly proliferative and differentiative, and may be used as a source for allograft transplantation, in order to decrease myocardial fibrosis, attenuate left ventricular remodeling, and improve heart function in doxorubicin-induced non-ischemic cardiomyopathy.
Collapse
Affiliation(s)
- Yong Sun
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Di Chi
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Miaoxin Tan
- Department of Cardiology, The First Hospital of Fangshan District, Beijing, china
| | - Kai Kang
- Department of Cardial Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Maomao Zhang
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Xiangyuan Jin
- Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Xiaoping Leng
- Department of Doppler Ultrasonic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Rui Cao
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Xianglan Liu
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Bo Yu
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| | - Jian Wu
- Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin Medical University, Harbin, China
- Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
| |
Collapse
|
4
|
Mansilla E, Marín GH, Berges M, Scafatti S, Rivas J, Núñez A, Menvielle M, Lamonega R, Gardiner C, Drago H, Sturla F, Portas M, Bossi S, Castuma MV, Peña Luengas S, Roque G, Martire K, Tau JM, Orlandi G, Tarditti A. Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns. BURNS & TRAUMA 2015; 3:17. [PMID: 27574663 PMCID: PMC4963940 DOI: 10.1186/s41038-015-0018-4] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/09/2015] [Accepted: 09/05/2015] [Indexed: 11/10/2022]
Abstract
BACKGROUND In January 2005, Rasulov et al. originally published "First experience in the use of bone marrow mesenchymal stem cells (MSCs) for the treatment of a patient with deep skin burns". Here, we present the first ever treated patient with cadaveric bone marrow mesenchymal stem cells (CMSCs) in the history of Medicine. METHODS A young man, who severely burned 60 % of his total body surface with 30 % of full-thickness burns while working with a grass trimmer that exploded, was involved in the study. MSCs were obtained from the bone marrow of a cadaver donor in a routine procurement procedure of CUCAIBA, the Province of Buenos Aires, Argentina, Ministry of Health, Transplantation Agency, cultured, expanded, and applied on the burned surfaces using a fibrin spray after early escharotomy. RESULTS So far, our preliminary experience and our early results have been very impressive showing an outstanding safety data as well as some impressive good results in the use of CMSCs. CONCLUSIONS Based on all this, we think that improvements in the use of stem cells for burns might be possible in the near future and a lot of time as well as many lives could be saved by many other research teams all over the world. CMSCs will probably be a real scientific opportunity in Regenerative Medicine as well as in Transplantation.
Collapse
Affiliation(s)
- Eduardo Mansilla
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Gustavo H Marín
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Mirta Berges
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Silvia Scafatti
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Jaime Rivas
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Andrea Núñez
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Martin Menvielle
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Roberto Lamonega
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Cecilia Gardiner
- Burns and Plastic Surgery Department, San Martín Hospital, Province of Buenos Aires Ministry of Health, La Plata, Province of Buenos Aires, Argentina
| | - Hugo Drago
- Burns Hospital, Buenos Aires City, Argentina
| | | | | | | | - Maria Victoria Castuma
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Sandra Peña Luengas
- Department of Chemistry, Mayaguez Campus, University of Puerto Rico, Mayaguez Puerto Rico, USA
| | - Gustavo Roque
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Karina Martire
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Jose Maria Tau
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Gabriel Orlandi
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| | - Adrian Tarditti
- Tissue Engineering, Regenerative Medicine and Cell Therapies Laboratory, CUCAIBA, Province of Buenos Aires Ministry of Health, Transplantation Program, La Plata, Province of Buenos Aires, Argentina
| |
Collapse
|
5
|
Valente S, Alviano F, Ciavarella C, Buzzi M, Ricci F, Tazzari PL, Pagliaro P, Pasquinelli G. Human cadaver multipotent stromal/stem cells isolated from arteries stored in liquid nitrogen for 5 years. Stem Cell Res Ther 2014; 5:8. [PMID: 24429026 PMCID: PMC4055119 DOI: 10.1186/scrt397] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Accepted: 01/06/2014] [Indexed: 12/16/2022] Open
Abstract
Introduction Regenerative medicine challenges researchers to find noncontroversial, safe and abundant stem cell sources. In this context, harvesting from asystolic donors could represent an innovative and unlimited reservoir of different stem cells. In this study, cadaveric vascular tissues were established as an alternative source of human cadaver mesenchymal stromal/stem cells (hC-MSCs). We reported the successful cell isolation from postmortem arterial segments stored in a tissue-banking facility for at least 5 years. Methods After thawing, hC-MSCs were isolated with a high efficiency (12 × 106) and characterized with flow cytometry, immunofluorescence, molecular and ultrastructural approaches. Results In early passages, hC-MSCs were clonogenic, highly proliferative and expressed mesenchymal (CD44, CD73, CD90, CD105, HLA-G), stemness (Stro-1, Oct-4, Notch-1), pericyte (CD146, PDGFR-β, NG2) and neuronal (Nestin) markers; hematopoietic and vascular markers were negative. These cells had colony and spheroid-forming abilities, multipotency for their potential to differentiate in multiple mesengenic lineages and immunosuppressive activity to counteract proliferation of phytohemagglutinin-stimulated blood mononuclear cells. Conclusions The efficient procurement of stem cells from cadaveric sources, as postmortem vascular tissues, demonstrates that such cells can survive to prolonged ischemic insult, anoxia, freezing and dehydration injuries, thus paving the way for a scientific revolution where cadaver stromal/stem cells could effectively treat patients demanding cell therapies.
Collapse
|